Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias

Free Radical Biology and Medicine

Volumn 41, Issue 10, 2006, Pages 1557-1565

  Jeffers, Anne ^a   Gladwin, Mark T ^b   Kim Shapiro, Daniel B ^a,c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c WAKE FOREST UNIVERSITY   (United States)

Author keywords

Red blood cell; Sickle cell disease; Vasodilation

Indexed keywords

HEME; HEMOGLOBIN; NITRIC OXIDE;

ARTICLE; BIOAVAILABILITY; CELL FUNCTION; CONCENTRATION RESPONSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ERYTHROCYTE MEMBRANE; EXTRAVASATION; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC ANEMIA; HUMAN; PLASMA; PRIORITY JOURNAL;

ANEMIA, HEMOLYTIC; BLOOD VESSELS; COMPUTER SIMULATION; HEMATOCRIT; HEMOGLOBINS; HEMOLYSIS; HUMANS; MODELS, BIOLOGICAL; NITRIC OXIDE;

EID: 33749677309     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2006.08.017     Document Type: Article

References (74)

1. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial-cells in the relaxation of arterial smooth-muscle by acetylcholine. Nature 288 (1980) 373-376
2. Ignarro L.J., Byrns R.E., Buga G.M., and Wood K.S. Endothelium-derived relaxing factor from pulmonary-artery and vein possesses pharmacological and chemical-properties identical to those of nitric-oxide radical. Circ. Res. 61 (1987) 866-879
3. Katsuki S., Arnold W., Mittal C., and Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric-oxide in various tissue preparations and comparison to effects of sodium azide and hydroxylamine. J. Cycl. Nucleotide Res. 3 (1977) 23-35
4. Palmer R.M.J., Ferrige A.G., and Moncada S. Nitric-oxide release accounts for the biological-activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
5. Ignarro L.J. Nitric oxide biology and pathobiology (2000), Academic Press, San Diego
6. Lancaster J.R. Simulation of the diffusion and reaction of endogenously produced nitric-oxide. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8137-8141
7. Coin J.T., and Olson J.S. Rate of oxygen-uptake by human red blood-cells. J. Biol. Chem. 254 (1979) 1178-1190
8. Butler A.R., Megson I.L., and Wright P.G. Diffusion of nitric oxide and scavenging by blood in the vasculature. Biochim. Biophys. Acta 1425 (1998) 168-176
9. Liu X.P., Miller M.J.S., Joshi M.S., Sadowska-Krowicka H., Clark D.A., and Lancaster J.R. Diffusion-limited reaction of free nitric oxide with erythrocytes. J. Biol. Chem. 273 (1998) 18709-18713
10. Vaughn M.W., Kuo L., and Liao J.C. Effective diffusion distance of nitric oxide in the microcirculation. Am. J. Physiol, Heart Circ. Physiol. 43 (1998) H1705-H1714
11. Liao J.C., Hein T.W., Vaughn M.W., Huang K.T., and Kuo L. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 8757-8761
12. Vaughn M.W., Huang K.T., Kuo L., and Liao J.C. Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J. Biol. Chem. 275 (2000) 2342-2348
13. Vaughn M.W., Huang K.T., Kuo L., and Liao J.C. Erythrocyte consumption of nitric oxide: competition experiment and model analysis. Nitric Oxide 5 (2001) 18-31
14. Liu X.P., Samouilov A., Lancaster J.R., and Zweier J.L. Nitric oxide uptake by erythrocytes is primarily limited by extracellular diffusion not membrane resistance. J. Biol. Chem. 277 (2002) 26194-26199
15. Huang K.T., Han T.H., Hyduke D.R., Vaughn M.W., Van Herle H., Hein T.W., Zhang C.H., Kuo L., and Liao J.C. Modulation of nitric oxide bioavailability by erythrocytes. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 11771-11776
16. Han T.H., and Liao J.C. Erythrocyte nitric oxide transport reduced by a submembrane cytoskeletal barrier. Biochim. Biophys. Acta 1723 (2005) 135-142
17. Azarov I., Huang K.T., Basu S., Gladwin M.T., Hogg N., and Kim-Shapiro D.B. Nitric oxide scavenging by red blood cells as a function of hematocrit and oxygenation. J. Biol. Chem. 280 (2005) 38032-39024
18. El-Farra N.H., Christofides P.D., and Liao J.C. Analysis of nitric oxide consumption by erythrocytes in blood vessels using a distributed multicellular model. Ann. Biomed. Eng. 31 (2003) 294-309
19. Han T.H., Qamirani E., Nelson A.G., Hyduke D.R., Chaudhuri G., Kuo L., and Liao J.C. Regulation of nitric oxide consumption by hypoxic red blood cells. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 12504-12509
20. Kim-Shapiro D.B., Schechter A.N., and Gladwin M.T. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 697-705
21. Lancaster J.R. Diffusion of free nitric oxide. Methods Enzymol. 268 (1996) 31-50
22. Buerk D.G. Can we model nitric oxide biotransport? A survey of mathematical models for a simple diatomic molecule with surprisingly complex biological activities. Annu. Rev. Biomed. Eng. 3 (2001) 109-143
23. Wood J., and Garthwaite J. Models of the diffusional spread of nitric-oxide- implications for neural nitric-oxide signaling and its pharmacological properties. Neuropharmacology 33 (1994) 1235-1244
24. Regirer S.A., and Shadrina N.K. Mathematical models of nitric oxide transport in a blood vessel. Biofizika 50 (2005) 515-536
25. Kavdia M., and Popel A.S. Venular endothelium-derived NO can affect paired arteriole: a computational model. Am. J. Physiol, Heart Circ. Physiol. 290 (2006) H716-H723
26. Zhang W.S., Pibulsonggram T., and Edwards A. Determinants of basal nitric oxide concentration in the renal medullary microcirculation. Am. J. Physiol.: Renal Physiol. 287 (2004) F1189-F1203
27. Ulatowski J.A., Koehler R.C., Nishikawa T., Traystman R.J., Razynska A., Kwansa H., Urbaitis B., and Bucci E. Role of nitric-oxide scavenging in peripheral vasoconstrictor response to beta-beta cross-linked hemoglobin. Artif. Cell Blood Substitutes 23 (1995) 263-269
28. Vogel W.M., Dennis R.C., Cassidy G., Apstein C.S., and Valeri C.R. Coronary constrictor effect of stroma-free hemoglobin-solutions. Am. J. Physiol. 251 (1986) H413-H420
29. Hess J.R., Macdonald V.W., and Brinkley W.W. Systemic and pulmonary-hypertension after resuscitation with cell-free hemoglobin. J. Appl. Physiol. 74 (1993) 1769-1778
30. Lee R., Neya K., Svizzero T.A., and Vlahakes G.J. Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J. Appl. Physiol. 79 (1995) 236-242
31. Murray J.A., Ledlow A., Launspach J., Evans D., Loveday M., and Conklin J.L. The effects of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 109 (1995) 1241-1248
32. Ulatowski J.A., Nishikawa T., MathesonUrbaitis B., Bucci E., Traystman R.J., and Koehler R.C. Regional blood flow alterations after bovine fumaryl beta beta-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition. Crit. Care Med. 24 (1996) 558-565
33. Sloan E.P., Koenigsberg M., Gens D., Cipolle M., Runge J., Mallory M.N., and Rodman G. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock-a randomized controlled efficacy trial. JAMA 282 (1999) 1857-1864
34. Dou Y., Maillett D.H., Eich R.F., and Olson J.S. Myoglobin as a model system for designing heme protein based blood substitutes. Biophys. Chem. 98 (2002) 127-148
35. Doherty D.H., Doyle M.P., Curry S.R., Vali R.J., Fattor T.J., Olson J.S., and Lemon D.D. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat. Biotechnol. 16 (1998) 672-676
36. Olson J.S., Foley E.W., Rogge C., Tsai A.L., Doyle M.P., and Lemon D.D. No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic. Biol. Med. 36 (2004) 685-697
37. Patel R.P. Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes. Free Radic. Biol. Med. 28 (2000) 1518-1525
38. Gulati A., Barve A., and Sen A.P. Pharmacology of hemoglobin therapeutics. J. Lab. Clin. Med. 133 (1999) 112-119
39. Abassi Z., Kotob S., Pieruzzi F., Abouassali M., Keiser K.R., Fratantoni J.C., and Alayash A.I. Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats. J. Lab. Clin. Med. 129 (1997) 603-610
40. Sharma A.C., Singh G., and Gulati A. Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats. Am. J. Physiol.: Heart Circ. Physiol. 38 (1995) H1379-H1388
41. Thompson A., McGarry A.E., Valeri C.R., and Lieberthal W. Stroma-free hemoglobin increases blood-pressure and Gfr in the hypotensive rat-role of nitric-oxide. J. Appl. Physiol. 77 (1994) 2348-2354
42. Sampei K., Ulatowski J.A., Asano Y., Kwansa H., Bucci E., and Koehler R.C. Role of nitric oxide scavenging in vascular response to cell-free hemoglobin transfusion. Am. J. Physiol.: Heart Circ. Physiol. 289 (2005) H1191-H1201
43. Alayash A.I. Hemoglobin-based blood substitutes: oxygen carriers, pressor agents, or oxidants?. Nat. Biotechnol. 17 (1999) 545-549
44. Rohlfs R.J., Bruner E., Chiu A., Gonzales A., Gonzales M.L., Magde D., Madge M.D., Vandegriff K.D., and Winslow R.M. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J. Biol. Chem. 273 (1998) 12128-12134
45. Winslow R.M. Current status of blood substitute research: towards a new paradigm. J. Intern. Med. 253 (2003) 508-517
46. Tsoukias N.M., Kavdia M., and Popel A.S. A theoretical model of nitric oxide transport in arterioles: frequency- vs. amplitude-dependent control of cGMP formation. Am. J. Physiol.: Heart Circ. Physiol. 286 (2004) H1043-H1056
47. Kavdia M., Tsoukias N.M., and Popel A.S. Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes. Am. J. Physiol.: Heart Circ. Physiol. 282 (2002) H2245-H2253
48. Pawloski J.R. Hemoglobin and nitric oxide. N. Engl. J. Med. 349 (2003) 403-404
49. Reiter C.D., and Gladwin M.T. An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr. Opin. Hematol. 10 (2003) 99-107
50. Reiter C.D., Wang X.D., Tanus-Santos J.E., Hogg N., Cannon R.O., Schechter A.N., and Gladwin M.T. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8 (2002) 1383-1389
51. Ballas S.K., and Marcolina M.J. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion 46 (2006) 105-110
52. Naumann H., Diggs L., Barreras L., and Williams B. Plasma hemoglobin and hemoglobin fractions in sickle cell crisis. Am. J. Clin. Pathol. 56 (1971) 137-147
53. Pohl U., and Lamontagne D. Impaired tissue perfusion after inhibition of endothelium-derived nitric-oxide. Basic Res. Cardiol. 86 (1991) 97-105
54. Gladwin M.T. Unraveling the hemolytic subphenotype of sickle cell disease. Blood 106 (2005) 2925-2926
55. Minneci P.C., Deans K.J., Huang Z., Yuen P.S.T., Star R.A., Banks S.M., Schechter A.N., Natanson C., Gladwin M.T., and Solomon S.B. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J. Clin. Invest. 115 (2005) 3409-3417
56. Nolan V.G., Wyszynski D.F., Farrer L.A., and Steinberg M.H. Hemolysis-associated priapism in sickle cell disease. Blood 106 (2005) 3264-3267
57. Rother R.P., Bell L., Hillmen P., and Gladwin M.T. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin-a novel mechanism of human disease. JAMA 293 (2005) 1653-1662
58. Morris C.R., Vichinsky E.P., Kato G.J., Gladwin M.T., Hazen S., and Morris S.M. Arginine metabolism, pulmonary hypertension, and sickle cell disease-in reply. JAMA 294 (2005) 2433-2434
59. Gladwin M.T., Sachdev V., Jison M.L., Shizukuda Y., Plehn J.F., Minter K., Brown B., Coles W.A., Nichols J.S., Ernst I., Hunter L.A., Blackwelder W.C., Schechter A.N., Rodgers G.P., Castro O., and Ognibene F.P. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N. Engl. J. Med. 350 (2004) 886-895
60. Kato G.J., McGowan V.R., Machado R.F., Little J.A., Taylor J., Morris C.R., Nichols J.S., Wang X., Poljakovic M., Morris J., Sidney M., and Gladwin M.T. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension and death in patients with sickle cell disease. Blood 107 (2006) 2279-2285
61. Pawloski J.R., Hess D.T., and Stamler J.S. Impaired vasodilation by red blood cells in sickle cell disease. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 2531-2536
62. Vaughn M.W., Kuo L., and Liao J.C. Estimation of nitric oxide production and reaction rates in tissue by use of a mathematical model. Am. J. Physiol.: Heart Circ. Physiol. 43 (1998) H2163-H2176
63. Malinski T., Taha Z., Grunfeld S., Patton S., Kapturczak M., and Tomboulian P. Diffusion of nitric oxide in the aorta wall monitored in situ by porphyrinic microsensors. Biochem. Biophys. Res. Commun. 193 (1993) 1076-1082
64. Takahashi Y., McCoy J., Carvallo C., Rivera C., Igarashi T., Srinivasan R., Young N.S., and Childs R.W. In vitro and in vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation. Blood 103 (2004) 1382-1390
65. Morris C.R., Kato G., Poljakovic M., Wang X., Blackwelder W.C., Sachdev V., Hazen S.L., Vichinsky E.P., Morris Jr. S.M., and Gladwin M.T. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294 (2005) 81-90
66. Boschetti C., Fermo E., Bianchi P., Vercellati C., Barraco F., and Zanella A. Clinical and molecular aspects of 23 patients affected by paroxysmal nocturnal hemoglobinuria. Am. J. Hematol. 77 (2004) 36-44
67. Tsoukias N.M., and Popel A.S. Erythrocyte consumption of nitric oxide in presence and absence of plasma-based hemoglobin. Am. J. Physiol.: Heart Circ. Physiol. 282 (2002) H2265-H2277
68. Tsai A.G., Acero C., Nance P.R., Cabrales P., Frangos J.A., Buerk D.G., and Intaglietta M. Elevated plasma viscosity in extreme hemodilution increases perivascular nitric oxide concentration and microvascular perfusion. Am. J. Physiol.: Heart Circ. Physiol. 288 (2005) H1730-H1739
69. Bohlen H.G., and Nase G.P. Dependence of intestinal arteriolar regulation on flow-mediated nitric oxide formation. Am. J. Physiol.: Heart Circ. Physiol. 279 (2000) H2249-H2258
70. Bellamy T.C., Wood J., and Garthwaite J. On the activation of soluble guanylyl cyclase by nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 507-510
71. Cary S.P.L., Winger J.A., and Marletta M.A. Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 13064-13069
72. Stone J.R., and Marletta M.A. Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide. Biochemistry 35 (1996) 1093-1099
73. Zhao Y., Brandish P.E., Ballou D.P., and Marletta M.A. A molecular basis for nitric oxide sensing by soluble guanylate cyclase. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 14753-14758
74. Russwurm M., Behrends S., Harteneck C., and Koesling D. Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochem. J. 335 (1998) 125-130